ATRC
AtriCure, Inc. NASDAQ Listed Aug 5, 2005$28.44
-1.25%
vs $28.80
Mkt Cap $1.4B
52w Low $25.86
15.6% of range
52w High $42.41
50d MA $28.02
200d MA $33.41
P/E (TTM)
-290.8x
EV/EBITDA
51.2x
P/B
2.8x
Debt/Equity
0.2x
ROE
-2.3%
P/FCF
28.1x
RSI (14)
62.30
ATR (14)
$1.14
Beta
1.43
50d MA
$28.02
200d MA
$33.41
Avg Volume
818.1K
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
7555 Innovation Way · Mason, OH 45040 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | -0.07 | 0.00 | +103.1% | 29.39 | -4.2% | -4.7% | -0.7% | -5.5% | +0.1% | +1.5% | — |
| Feb 17, 2026 | AMC | -0.04 | 0.06 | +249.8% | 32.97 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% | — |
| Oct 29, 2025 | AMC | -0.11 | -0.01 | +90.9% | 35.44 | +4.0% | -3.8% | +1.3% | -1.5% | -3.8% | -1.3% | — |
| Jul 29, 2025 | AMC | -0.15 | -0.02 | +86.7% | 31.73 | +18.8% | +10.7% | -0.1% | -2.0% | +5.6% | +3.3% | — |
| Apr 29, 2025 | AMC | -0.25 | -0.14 | +44.0% | 34.65 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% | — |
| Feb 12, 2025 | AMC | -0.23 | -0.08 | +65.2% | 42.36 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% | — |
| Oct 29, 2024 | AMC | -0.20 | -0.17 | +15.0% | 29.43 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% | — |
| Jul 30, 2024 | AMC | -0.15 | -0.17 | -13.3% | 22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% | — |
| May 1, 2024 | AMC | -0.21 | -0.25 | -19.0% | 24.76 | -8.4% | -10.3% | -6.0% | +5.8% | -1.0% | -5.4% | — |
| Feb 15, 2024 | AMC | -0.22 | -0.21 | +4.5% | 34.21 | -0.2% | -4.4% | +0.9% | +0.1% | +2.9% | -1.3% | — |
| Nov 1, 2023 | AMC | -0.30 | -0.20 | +33.3% | 35.01 | +8.3% | +4.5% | +1.1% | +2.4% | -1.0% | -1.2% | — |
| Jul 25, 2023 | AMC | -0.27 | -0.12 | +55.6% | 53.19 | +6.7% | +8.5% | -5.2% | +1.1% | +0.0% | +1.6% | — |
| May 2, 2023 | AMC | -0.34 | -0.23 | +32.4% | 43.94 | +7.2% | +10.0% | -2.5% | +2.6% | -1.2% | +0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 | UBS | Maintains | Buy → Buy | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 18 | BTIG | Maintains | Buy → Buy | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 18 | Oppenheimer | Downgrade | Outperform → Perform | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 18 | Citizens | Maintains | Market Outperform → Market Outperform | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 18 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.97 | $33.00 | +0.1% | -2.2% | +0.4% | +0.6% | -2.4% | -2.0% |
| Feb 12 | Needham | Maintains | Buy → Buy | — | $32.90 | $33.01 | +0.3% | -3.3% | +2.7% | +1.0% | -2.2% | +0.4% |
| Dec 16 | JP Morgan | Maintains | Overweight → Overweight | — | $41.04 | $41.35 | +0.8% | +0.1% | -0.7% | -1.0% | +1.4% | +1.7% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $35.44 | $36.86 | +4.0% | -3.8% | +1.3% | -1.5% | -3.8% | -1.3% |
| Jul 30 | Needham | Maintains | Buy → Buy | — | $31.73 | $37.70 | +18.8% | +10.7% | -0.1% | -2.0% | +5.6% | +3.3% |
| Apr 30 | Needham | Maintains | Buy → Buy | — | $34.65 | $31.18 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% |
| Apr 30 | BTIG | Maintains | Buy → Buy | — | $34.65 | $31.18 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% |
| Apr 30 | UBS | Maintains | Buy → Buy | — | $34.65 | $31.18 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% |
| Apr 30 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $34.65 | $31.18 | -10.0% | -13.7% | -2.1% | +2.5% | -3.2% | +2.7% |
| Apr 2 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $33.36 | $32.52 | -2.5% | +2.3% | -3.5% | -4.9% | +0.9% | -3.1% |
| Mar 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $34.37 | $33.83 | -1.6% | -7.4% | +1.4% | +3.4% | +2.3% | -3.5% |
| Mar 27 | Needham | Maintains | Buy → Buy | — | $33.62 | $33.83 | +0.6% | +2.2% | -7.4% | +1.4% | +3.4% | +2.3% |
| Mar 27 | BTIG | Maintains | Buy → Buy | — | $33.62 | $33.83 | +0.6% | +2.2% | -7.4% | +1.4% | +3.4% | +2.3% |
| Mar 27 | JP Morgan | Maintains | Overweight → Overweight | — | $33.62 | $33.83 | +0.6% | +2.2% | -7.4% | +1.4% | +3.4% | +2.3% |
| Mar 21 | Needham | Maintains | Buy → Buy | — | $34.82 | $34.53 | -0.8% | -3.7% | +4.6% | -0.7% | -3.5% | +2.2% |
| Feb 13 | Oppenheimer | Maintains | Outperform → Outperform | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | Needham | Maintains | Buy → Buy | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | BTIG | Maintains | Buy → Buy | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | Stifel | Maintains | Buy → Buy | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $42.36 | $42.00 | -0.8% | -6.5% | +3.4% | -6.6% | +2.1% | +0.4% |
| Feb 11 | JP Morgan | Maintains | Overweight → Overweight | — | $42.02 | $41.93 | -0.2% | -1.2% | +2.0% | -6.5% | +3.4% | -6.6% |
| Feb 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $41.00 | $41.48 | +1.2% | +2.5% | -1.2% | +2.0% | -6.5% | +3.4% |
| Jan 22 | Needham | Maintains | Buy → Buy | — | $39.63 | $39.82 | +0.5% | -0.3% | +2.2% | +0.5% | +0.6% | +3.1% |
| Jan 13 | Needham | Maintains | Buy → Buy | — | $31.41 | $33.07 | +5.3% | +9.5% | +0.9% | +6.6% | +1.8% | +2.2% |
| Dec 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $34.25 | $34.56 | +0.9% | -0.9% | +0.1% | -2.0% | -1.6% | -3.4% |
| Oct 30 | UBS | Maintains | Buy → Buy | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Oct 30 | Needham | Maintains | Buy → Buy | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Oct 30 | Oppenheimer | Maintains | Outperform → Outperform | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Oct 30 | JP Morgan | Maintains | Overweight → Overweight | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Oct 30 | Canaccord Genuity | Maintains | Buy → Buy | — | $29.43 | $34.40 | +16.9% | +18.3% | -4.7% | +1.0% | +0.4% | +5.4% |
| Jul 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 31 | BTIG | Maintains | Buy → Buy | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 31 | Needham | Maintains | Buy → Buy | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 31 | Stifel | Maintains | Buy → Buy | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 31 | JP Morgan | Maintains | Overweight → Overweight | — | $22.00 | $22.00 | +0.0% | -2.0% | -2.5% | +4.8% | -2.8% | +0.6% |
| Jul 8 | Needham | Maintains | Buy → Buy | — | $23.67 | $23.82 | +0.6% | -7.7% | +1.8% | -0.2% | +5.4% | -0.9% |
| May 2 | Canaccord Genuity | Maintains | Buy → Buy | — | $24.76 | $22.69 | -8.4% | -10.3% | -6.0% | +5.8% | -1.0% | -5.4% |
| May 2 | Needham | Maintains | Buy → Buy | — | $24.76 | $22.69 | -8.4% | -10.3% | -6.0% | +5.8% | -1.0% | -5.4% |
| May 2 | JP Morgan | Maintains | Overweight → Overweight | — | $24.76 | $22.69 | -8.4% | -10.3% | -6.0% | +5.8% | -1.0% | -5.4% |
| Apr 23 | Oppenheimer | Upgrade | Perform → Outperform | — | $22.71 | $23.92 | +5.3% | +2.0% | -0.5% | -1.9% | +2.5% | +0.9% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $27.61 | $26.59 | -3.7% | -6.2% | -2.3% | -4.8% | -4.9% | +0.9% |
| Feb 16 | Needham | Maintains | Buy → Buy | — | $34.21 | $34.15 | -0.2% | -4.4% | +0.9% | +0.1% | +2.9% | -1.3% |
| Feb 16 | UBS | Maintains | Buy → Buy | — | $34.21 | $34.15 | -0.2% | -4.4% | +0.9% | +0.1% | +2.9% | -1.3% |
| Feb 16 | Stifel | Maintains | Buy → Buy | — | $34.21 | $34.15 | -0.2% | -4.4% | +0.9% | +0.1% | +2.9% | -1.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Doraiswamy VinayakOff | Chief Scientific Officer | Sell | 5,000 | $28.13 | $141K | 91,875 | +1.12% | +1.84% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Hood River Capital Management Llc | 3,117,545 | $89M | Added | Mar 2026 |
| 2 | Vanguard Portfolio Management Llc | 2,702,632 | $77M | New | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 2,155,764 | $62M | New | Mar 2026 |
| 4 | Marshall Wace, Llp | 1,467,524 | $42M | Added | Mar 2026 |
| 5 | Divisadero Street Capital Management, Lp | 1,159,955 | $33M | New | Mar 2026 |
| 6 | Bnp Paribas Asset Management Holding S.a. | 1,060,806 | $30M | Added | Mar 2026 |
| 7 | Neuberger Berman Group Llc | 1,050,282 | $30M | Reduced | Mar 2026 |
| 8 | Voya Investment Management Llc | 712,329 | $28M | Added | Dec 2025 |
| 9 | Champlain Investment Partners, Llc | 971,111 | $28M | Reduced | Mar 2026 |
| 10 | Morgan Stanley | 692,232 | $27M | Added | Dec 2025 |
| 11 | Bank Of America Corp /de/ | 768,561 | $22M | Added | Mar 2026 |
| 12 | Two Sigma Investments, Lp | 751,003 | $21M | Added | Mar 2026 |
| 13 | Connor, Clark & Lunn Investment Management Ltd. | 378,496 | $15M | Added | Dec 2025 |
| 14 | First Eagle Investment Management, Llc | 524,286 | $15M | Added | Mar 2026 |
| 15 | Qube Research & Technologies Ltd | 454,791 | $13M | Added | Mar 2026 |
| 16 | Northern Trust Corp | 449,599 | $13M | Added | Mar 2026 |
| 17 | Fmr Llc | 336,814 | $10M | Added | Mar 2026 |
| 18 | Nuveen, Llc | 336,727 | $10M | — | Mar 2026 |
| 19 | Renaissance Technologies Llc | 308,700 | $9M | Reduced | Mar 2026 |
| 20 | Arrowstreet Capital, Limited Partnership | 277,682 | $8M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.36B
Enterprise Value
$1.26B
P/E (TTM)
-290.80x
Forward P/E
379.20x
PEG Ratio
2.21x
P/B
2.76x
P/S
2.46x
P/FCF
28.13x
EV/EBITDA
51.17x
Shares Out
47.8M
Financials (TTM)
Revenue
$552.2M
Net Income
-$4.6M
EBITDA
$24.7M
Free Cash Flow
$48.3M
Op Cash Flow
$57.3M
EPS Basic
$-0.24
EPS Diluted
$-0.10
EPS Forward
$0.07
Gross Margin
75.5%
Op Margin
-0.4%
Net Margin
-0.8%
Balance Sheet
Total Assets
$654.2M
Total Liab.
$162.2M
Total Equity
$491.9M
Cash
$167.4M
LT Debt
$73.4M
Book Value/Sh
$10.30
Debt/Equity
0.18x
Current Ratio
3.96
Quick Ratio
2.99
Returns & Growth
ROE
-2.3%
ROA
-1.8%
ROIC
-0.6%
Rev Growth YoY
+14.9%
EPS Growth YoY
+74.7%
Price Returns
2W
-1.7%
1M
-1.6%
3M
-11.5%
6M
-23.4%
12M
-20.0%
Technicals
52W High
$42.41
52W Low
$25.86
50d MA
$28.02
200d MA
$33.41
RSI (14)
62.30
ATR (14)
$1.14
Beta
1.43
Avg Volume
818K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$50.67
High
$55.00
Low
$44.00
Median
$53.00
Data updated apr 24, 2026 7:42pm
· Source: financialmodelingprep.com